231 related articles for article (PubMed ID: 34660731)
1. Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
Wang X; Luo Y; Xu D; Zhao K
Front Cardiovasc Med; 2021; 8():731135. PubMed ID: 34660731
[No Abstract] [Full Text] [Related]
2. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
[TBL] [Abstract][Full Text] [Related]
3. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses.
Gazzaniga G; Menichelli D; Scaglione F; Farcomeni A; Pani A; Pastori D
Eur J Clin Pharmacol; 2023 Apr; 79(4):473-483. PubMed ID: 36872367
[TBL] [Abstract][Full Text] [Related]
4. Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality.
Chamaria S; Desai AM; Reddy PC; Olshansky B; Dominic P
Cardiol Res Pract; 2015; 2015():314041. PubMed ID: 26788401
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation.
Qureshi W; O'Neal WT; Soliman EZ; Al-Mallah MH
Cardiol J; 2016; 23(3):333-43. PubMed ID: 27064796
[TBL] [Abstract][Full Text] [Related]
6. Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
Chen Y; Cai X; Huang W; Wu Y; Huang Y; Hu Y
Medicine (Baltimore); 2015 Dec; 94(52):e2409. PubMed ID: 26717399
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update.
Vamos M; Erath JW; Benz AP; Lopes RD; Hohnloser SH
Am J Cardiol; 2019 Jan; 123(1):69-74. PubMed ID: 30539748
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
Botis M; Kartas A; Samaras A; Akrivos E; Vrana E; Liampas E; Papazoglou AS; Moysidis DV; Papanastasiou A; Baroutidou A; Karvounis H; Tzikas A; Parissis J; Drakos SG; Giannakoulas G
Hellenic J Cardiol; 2022; 68():25-32. PubMed ID: 36037999
[TBL] [Abstract][Full Text] [Related]
9. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.
Elayi CS; Shohoudi A; Moodie E; Etaee F; Guglin M; Roy D; Khairy P;
Int J Cardiol; 2020 Aug; 313():48-54. PubMed ID: 32320783
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation.
Ouyang AJ; Lv YN; Zhong HL; Wen JH; Wei XH; Peng HW; Zhou J; Liu LL
Am J Cardiol; 2015 Apr; 115(7):901-6. PubMed ID: 25660972
[TBL] [Abstract][Full Text] [Related]
11. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
[TBL] [Abstract][Full Text] [Related]
12. [The impact of digoxin on the long-term outcomes in patients with coronary artery disease and atrial fibrillation].
Qiao Y; Wang Y; Jiang CX; Li SN; Sang CH; Tang RB; Long DY; Wu JH; He L; Du X; Dong JZ; Ma CS
Zhonghua Nei Ke Za Zhi; 2021 Sep; 60(9):797-805. PubMed ID: 34445815
[No Abstract] [Full Text] [Related]
13. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry.
Ding WY; Boriani G; Marin F; Blomström-Lundqvist C; Potpara TS; Fauchier L; Lip GYH;
Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):372-382. PubMed ID: 34665249
[TBL] [Abstract][Full Text] [Related]
15. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
[TBL] [Abstract][Full Text] [Related]
16. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
[TBL] [Abstract][Full Text] [Related]
17. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
[TBL] [Abstract][Full Text] [Related]
18. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
Turakhia MP; Santangeli P; Winkelmayer WC; Xu X; Ullal AJ; Than CT; Schmitt S; Holmes TH; Frayne SM; Phibbs CS; Yang F; Hoang DD; Ho PM; Heidenreich PA
J Am Coll Cardiol; 2014 Aug; 64(7):660-8. PubMed ID: 25125296
[TBL] [Abstract][Full Text] [Related]
19. Digoxin and Mortality in Patients With Atrial Fibrillation.
Lopes RD; Rordorf R; De Ferrari GM; Leonardi S; Thomas L; Wojdyla DM; Ridefelt P; Lawrence JH; De Caterina R; Vinereanu D; Hanna M; Flaker G; Al-Khatib SM; Hohnloser SH; Alexander JH; Granger CB; Wallentin L;
J Am Coll Cardiol; 2018 Mar; 71(10):1063-1074. PubMed ID: 29519345
[TBL] [Abstract][Full Text] [Related]
20. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
